Do biologics help taper steroids in Adult Still’s Disease? A Japanese large scale claims data study presented at #AC

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Do biologics help taper steroids in Adult Still’s Disease? A Japanese large scale claims data study presented at #ACR22 (abstract#0826) was able to collect 5-year data to study the treatment patterns in Still’s. https://t.co/S0HMfWuUai https://t.co/ZKV0aP900w
Links
https://bit.ly/3X2XQBw

Anifrolumab shows long-term promise in patients with lupus Researchers report positive results from the first placebo-

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Anifrolumab shows long-term promise in patients with lupus Researchers report positive results from the first placebo-controlled long-term trial of anifrolumab—a human monoclonal antibody that targets the type I IFN receptor—in patients with lupus. https://t.co/sYzLMgLzqy https://t.co/fdmhYONI3G
Links
https://bit.ly/3tB7uhf

Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial Dr. Michael Putman interviews Dr. Robert Speira about a

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at #ACR22. https://t.co/nJAOBDC8KX https://t.co/Tgls8O4AVC
Links
https://bit.ly/3UUctoK

Why Clinical Trials?

Psoriatic Arthritis Topic Panel: ACR22

Peresolimab for RA: Phase 2a Results

16 November 2022
RA-ILD takes centre stage
Interstitial lung disease is common in RA, occurring in approximately 8% of RA patients. It is associated with a poor prognosis, and a median survival of 3 years. This important condition has often been neglected within the spectrum of RA research. That is changing, with excellent research initiatives presented at ACR22. I am going to highlight two select abstracts from Monday’s dedicated RA-ILD session.
16 November 2022
More Than a Conference: Life’s Lessons

Conferences are held for the purposes of sharing ideas, developing new relationships, and collaborating on future research. The American College of Rheumatology (ACR) Convergence 2022 meeting embodies all these ideals by offering both in-person and virtual attendance options. However, when a conference ends, what happens to the attendees? Will they remember what they learned? Will they incorporate new ideas into their practice? How have they changed? 

Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE

Subscribe to
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×